AxoGen (AXGN) Reports In-Line Q3 EPS

AxoGen (NASDAQ: AXGN) reported Q3 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $22.52 million.

GUIDANCE:

2018 Financial Guidance Management reiterates 2018 revenue will grow at least 40% over 2017 revenue and gross margins will remain above 80%. Additionally, management continues to expect to have at least 80 direct sales representatives by year end.

Introducing 2019 Financial Guidance Management expects full year 2019 revenue will grow at least 35% over 2018 revenue and gross margins will remain above 80%.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Ulta Beauty (ULTA) Tops Q1 EPS by 87c, Beats on Revenue; Offers FY27 EPS guidance
• CrowdStrike posts record ARR growth, raises full-year outlook